Explore more publications!
Tech Journal of Colorado
Submit Press Release

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 3, 2025

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
November 3, 2025

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting

Indeterminate GlobeNewswire
AI/R’s Avenue Code Launches ChatGPT Commerce Solution
November 3, 2025

AI/R’s Avenue Code Launches ChatGPT Commerce Solution

Indeterminate GlobeNewswire
Cloudera Named A Leader in 2025 Data Fabric Platforms Report by Independent Analyst Firm
November 3, 2025

Cloudera Named A Leader in 2025 Data Fabric Platforms Report by Independent Analyst Firm

Indeterminate GlobeNewswire
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
November 3, 2025

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
November 3, 2025

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting

Indeterminate GlobeNewswire
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
November 3, 2025

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Indeterminate GlobeNewswire
Octaura Expands Management Team, Appoints Cristina Kim as Chief Financial Officer
November 3, 2025

Octaura Expands Management Team, Appoints Cristina Kim as Chief Financial Officer

Indeterminate GlobeNewswire
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting
November 3, 2025

SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
March Biosciences Announces Oral Presentation of MB-105 Interim Phase 2 Clinical Data at American Society of Hematology Annual Meeting
November 3, 2025

March Biosciences Announces Oral Presentation of MB-105 Interim Phase 2 Clinical Data at American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Aptose Tuspetinib Clinical Data from Ongoing TUSCANY Trial in Newly Diagnosed AML Selected for Presentation at the 2025 ASH Annual Meeting
November 3, 2025

Aptose Tuspetinib Clinical Data from Ongoing TUSCANY Trial in Newly Diagnosed AML Selected for Presentation at the 2025 ASH Annual Meeting

Indeterminate GlobeNewswire
New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting
November 3, 2025

New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting

Indeterminate GlobeNewswire
Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
November 3, 2025

Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Phosphorus Declares Independence from Opaque CPS Security Pricing and Passive Discovery Vendors
November 3, 2025

Phosphorus Declares Independence from Opaque CPS Security Pricing and Passive Discovery Vendors

Indeterminate GlobeNewswire
Fullstory acquires Usetiful, turning digital insights into decisive actions
November 3, 2025

Fullstory acquires Usetiful, turning digital insights into decisive actions

Indeterminate GlobeNewswire
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting
November 3, 2025

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

Indeterminate GlobeNewswire
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
November 3, 2025

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition
November 3, 2025

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire
IPSIPAY to launch next-generation Crypto Payment Platform
November 3, 2025

IPSIPAY to launch next-generation Crypto Payment Platform

Indeterminate GlobeNewswire
Stride, Inc. Authorizes $500 Million Stock Repurchase Program
November 3, 2025

Stride, Inc. Authorizes $500 Million Stock Repurchase Program

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions